Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:56 pm Purchase |
2025-04-09 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 999,414 9.100% |
999,414 (New Position) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 1,093,499 9.990% |
390,373 (+55.52%) |
Filing History |
| 2024-12-09 5:37 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% |
600,157 (New Position) |
Filing History |
| 2024-12-04 4:15 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
Venrock Healthcare Capital Partners III L.P. | 1,129,097 9.990% |
1,129,097 (New Position) |
Filing History |
| 2024-12-03 4:34 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
TCG Crossover GP II, LLC | 1,005,901 9.200% |
1,005,901 (New Position) |
Filing History |
| 2024-11-26 5:32 pm Purchase |
2024-11-26 | 13D | Cidara Therapeutics, Inc. CDTX |
RA Capital Management, L.P. | 1,092,796 9.990% |
389,716 (+55.43%) |
Filing History |
| 2024-11-14 4:22 pm Purchase |
2024-09-30 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 703,126 9.990% |
703,126 (New Position) |
Filing History |
| 2024-07-29 4:45 pm Purchase |
2024-07-18 | 13G | Cidara Therapeutics, Inc. CDTX |
BCLS Fund III Investments, LP | 703,080 9.990% |
703,080 (New Position) |
Filing History |
| 2024-07-29 4:31 pm Purchase |
2024-07-18 | 13G | Cidara Therapeutics, Inc. CDTX |
Canaan XII L.P. | 1,400,000 9.990% |
1,400,000 (New Position) |
Filing History |
| 2024-07-25 4:16 pm Purchase |
2024-07-18 | 13D | Cidara Therapeutics, Inc. CDTX |
RA Capital Management, L.P. | 703,080 9.990% |
703,080 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 77,337 1.700% |
-141,036 (-64.58%) |
Filing History |
| 2024-02-14 10:18 am Purchase |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 463,776 9.990% |
120,720 (+35.19%) |
Filing History |
| 2024-02-14 10:02 am Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 62,511 1.400% |
-130,889 (-67.68%) |
Filing History |
| 2023-02-14 4:58 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 218,373 6.100% |
-45,150 (-17.13%) |
Filing History |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 193,400 5.400% |
-22,502 (-10.42%) |
Filing History |
| 2022-02-15 1:09 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 85,416 2.500% |
-81,604 (-48.86%) |
Filing History |
| 2022-02-14 4:48 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Omega Fund V L.P. | 62,500 1.800% |
-100,262 (-61.60%) |
Filing History |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 215,902 6.500% |
5,902 (+2.81%) |
Filing History |
| 2022-02-14 08:30 am Purchase |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 263,523 7.900% |
263,523 (New Position) |
Filing History |
| 2022-02-11 4:48 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BB BIOTECH AG | 0 0.000% |
-141,125 (Position Closed) |
Filing History |